Inhibitory efficacy of 2, 4-diacetylphloroglucinol against SARS-COV-2 proteins: in silico study

The pandemic of Severe Acute Respiratory Syndrome Coronavirus-2 has affected millions of people worldwide with common symptoms of fever, cough, and respiratory complications. The pandemic has posed a huge challenge to emergency health services due to unavailability of potent therapeutic drugs. The p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kankariya, Raksha A., Chaudhari, Ambalal B., Dandi, Navin D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800849/
https://www.ncbi.nlm.nih.gov/pubmed/35125499
http://dx.doi.org/10.1007/s11756-021-00979-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800849/
https://www.ncbi.nlm.nih.gov/pubmed/35125499
http://dx.doi.org/10.1007/s11756-021-00979-4

Ejemplares similares